Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026Unusual Whales·Jul 22 at 03:03 PMEBS+2.16%
Emergent BioSolutions schedules second-quarter 2026 results conference callPUBT·Jul 22 at 03:01 PMEBS+2.16%
Emergent's CEO shares what he looks for in developers in the AI erabusinessinsider·Jul 15 at 02:40 PMEBS+2.16%
BlueOne net loss widens to $4.1 million in FY26; revenue rises to $260,013PUBT·Jul 14 at 05:02 AMEBS+2.16%
Emergent BioSolutions SVP Paul Anthony Williams sells 3,000 shares for $25,200PUBT·Jul 2 at 11:58 AMEBS+2.16%
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government | EBS Stock NewsStockTitan·Jun 29 at 12:13 AMEBS+2.16%
Emergent Biosolutions Inc. (NYSE:EBS) Receives Consensus Recommendation of "Hold" from AnalystsMarket Beat·Jun 2 at 09:17 AMEBS+2.16%
Emergent BioSolutions Receives Saudi Food and Drug Authority Approval for ACAM2000® [Smallpox and Mpox (Vaccinia) Vaccine, Live] | EBS Stock NewsStockTitan·May 17 at 11:59 PMEBS+2.16%
Emergent BioSolutions Shares Turnaround Update at 2026 Annual Meeting; All Proposals ApprovedMarket Beat·May 2 at 09:29 AMEBS+2.16%PBE+1.52%
Emergent BioSolutions Earnings Call Highlights Turnaround MomentumTip Ranks·May 1 at 07:45 PMEBS+2.16%FBT+0.66%
Riot Platforms Q1 2026 Earnings Call: Complete Transcriptbenzinga_article·Apr 30 at 04:50 PMRIOT+0.65%GBTC+0.61%
